Skip to content

Perspective Therapeutics CATX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$230.43K+2,692%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Precigen logo
PrecigenPGEN
$4.73M-12.7%
Zymeworks logo
ZymeworksZYME
$17.04M-7.5%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$33.57M
Roivant Sciences logo
Roivant SciencesROIV
$107.44M+7.3%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's operating lease liabilities (total)?
Perspective Therapeutics (CATX) reported operating lease liabilities (total) of $2.62M in Q1 2026.
How has Perspective Therapeutics's operating lease liabilities (total) changed year-over-year?
Perspective Therapeutics's operating lease liabilities (total) increased by 21.7% year-over-year, from $2.15M to $2.62M.
What is the long-term trend for Perspective Therapeutics's operating lease liabilities (total)?
Over 4 years (2020 to 2025), Perspective Therapeutics's operating lease liabilities (total) has grown at a 16.1% compound annual growth rate (CAGR), from $897K to $1.63M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.